Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum CytoDyn Inc CYDY

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. The Company is studying leronlimab in multiple therapeutic areas, including... see more

OTCQB:CYDY - Post Discussion

CytoDyn Inc > Thank you Dr. J & Mgt, BOD & Advisors !!
View:
Post by My19sixyNineZ on Mar 04, 2024 11:40pm

Thank you Dr. J & Mgt, BOD & Advisors !!

Trying to give thanks @  Yazooo & keeps deleting. 

 

They've  tossed tha baby out with the bath water AND did a remodeling.

 

I could laundry list the good & then bad i pointed out --- also how bad i was bad mouthed. Both sides of my DD was correct.

 

Remember also was me who pointed out when it was said the 2 Vs 4 dosing was questioned. It caused all those comments / letters / videos, from doctors, etc., about the FDA.

 

Couple months later FDA broke tradition & issued that un-signed letter.

 

My point is, the voice of that webinar comments was ---- Dr. J.
 

His honesty on the dosing to the shareholders, earned my respect from there frwd.

Phenominal hearing him now say --- Cytodyn finally, has a working, collaborating relationship with the FDA & how grateful he is for their in-put, for succeeding. Awesome.

 

From Interim CEO webinar, he is hitting the milestones stated. CEO position to expand all things mentioned.

 

So good to see this cleaned-up & safe for trials, in 24 months. Staggering time actually.

 

The world needs Leronlimab & regardless of indication direction, i absolutely trust Dr. J 100%!!

GLTA!!

Be the first to comment on this post